DiaCarta

3535 Breakwater Ave.
Hayward, CA 94545 USA
Phone
Fax
Click for website

Research Sector

Summary Description DiaCarta is a medical diagnostics company that is dedicated to improving patient care through novel precision molecular diagnostics: CE/IVD marked tests are available for detection of KRAS, NRAS, EGFR, BRAF, PIK3CA, JAK2 and customizing. HPV QuantiVirus® cervical and head-neck cancer tests allow detection of oncogenic E6/E7 mRNAs from 14 high-risk subtypes and genotyping of HPV 16 and 18, in one simple assay.

Management Aiguo Zhang, Ph.D, President and CEO, Founder; Paul Okunieff, M.D., Founder, Chief Medical Officer; Michael J. Powell, Ph.D, Chief Scientific Officer; David Broecker, MBA, Chief Commercial Officer

Click here for Financial Data
Keywords: cancer, oncology, treatment, diagnostics, molecular diagnostics, hpv

Comment


Updated: Aug. 30, 2017


Description

DiaCarta is a medical diagnostics company that is dedicated to improving patient care through novel precision molecular diagnostics: CE/IVD marked tests are available for detection of KRAS, NRAS, EGFR......view more

Products / Services

QClamp KRAS Mutation Test Kit (CE/IVD) Exon 2, Exon 3, Exon 4 QClamp NRAS Mutation Test Kit (CE/IVD) Exon 2, Exon 3, Exon 4 QClamp EGFR Mutation Test Kit (CE/IVD) Exon ......view more

Technology / Differentiation

DiaCarta's proprietary QClamp Somatic Mutation Detection technology is based on xenonucleic acid "Clamp" (XNA Clamp); e.g. PNA (peptide nucleic acid) or GNA (glycol nucleic acid) or other suitable mo...view more

RELATED COMPANIES